Pharmacodynamics of benserazide as assessed by its effects on endogenous and exogenous levodopa pharmacokinetics.

被引：0
|
作者：
Crevoisier, C
Dingemanse, J
Zurcher, G
McClelland, G
机构：
[1] F HOFFMANN LA ROCHE & CO LTD, DEPT CLIN PHARMACOL, CH-4002 BASEL, SWITZERLAND
[2] F HOFFMANN LA ROCHE & CO LTD, PRECLIN RES, CH-4002 BASEL, SWITZERLAND
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1997年 / 61卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：PII69 / PII69
页数：1
相关论文
共 30 条
  • [1] Pharmacodynamics of benserazide assessed by its effects on endogenous and exogenous levodopa pharmacokinetics
    Dingemanse, J
    Kleinbloesem, CH
    Zurcher, G
    Wood, ND
    Crevoisier, C
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 44 (01) : 41 - 48
  • [2] Gender and pramipexole effects on levodopa pharmacokinetics and pharmacodynamics
    Kompoliti, K
    Adler, CH
    Raman, R
    Pincus, JH
    Leibowitz, MT
    Ferry, JJ
    Blasucci, L
    Caviness, JN
    Leurgans, S
    Chase, WM
    Yones, LC
    Tan, E
    Carvey, P
    Goetz, CG
    NEUROLOGY, 2002, 58 (09) : 1418 - 1422
  • [3] Gender and pramipexole effects on levodopa pharmacokinetics and pharmacodynamics
    Zappia, M
    Quattrone, A
    NEUROLOGY, 2002, 59 (12) : 2010 - 2010
  • [4] TOLERABILITY AND PHARMACOKINETICS OF TRANS-RESVERATROL AND ITS EFFECT ON THE LEVODOPA PHARMACOKINETICS FOLLOWING 100/25 MG LEVODOPA/BENSERAZIDE
    Almeida, L.
    Rocha, J. -F
    Falcao, A.
    Nunes, T.
    Fernandes-Lopes, C.
    Costa, R.
    Loureiro, A.
    Soares, E.
    Mota, F.
    Wright, L.
    Vaz-da-Silva, M.
    Soares-da-Silva, P.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 105 : 108 - 109
  • [5] PHARMACOKINETICS AND PHARMACODYNAMICS OF ENDOGENOUS AND EXOGENOUS CORTISOL IN PREMENOPAUSAL, HEALTHY WOMEN
    Authement, Aurora
    Amory, John K.
    Czuba, Lindsay C.
    Yadav, Aprajita S.
    Zhu, Jerry
    Rubinow, Katya B.
    Isoherranen, Nina
    DRUG METABOLISM AND PHARMACOKINETICS, 2024, 55
  • [6] Effects of caffeine on levodopa pharmacokinetics and pharmacodynamics in Parkinson disease
    Deleu, D.
    Jacob, P.
    Chand, P.
    Sarre, S.
    Colwell, A.
    NEUROLOGY, 2006, 67 (05) : 897 - 899
  • [7] Effects of age and gender on febuxostat pharmacokinetics. Pharmacodynamics, and safety in healthy subjects.
    Khosravan, R
    Kukulka, M
    Wu, JT
    Joseph-Ridge, N
    Vernillet, L
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P50 - P50
  • [8] RELEVANCE OF EXOGENOUS AND ENDOGENOUS GROWTH-HORMONE ON THE LEVODOPA CEREBRAL EFFECTS
    PAPAVASILIOU, P
    MCDOWELL, FH
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1979, 6 (01) : 87 - 87
  • [9] EFFECTS OF AN INHIBITOR OF CATECHOL-O-METHYL TRANSFERASE (COMT) ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF LEVODOPA
    NUTT, JG
    WOODWARD, WR
    STONE, CK
    BECKNER, RM
    CARTER, JH
    GANCHER, ST
    HAMMERSTAD, JP
    GORDIN, A
    NEUROLOGY, 1993, 43 (04) : A332 - A332
  • [10] Effects of Unsuppressed Endogenous Insulin on Pharmacokinetics and/or Pharmacodynamics of Study Insulin in the Healthy: A Retrospective Study
    Liu, Hui
    Yu, Hongling
    Sun, Lisi
    Qiao, Jingtao
    Li, Jiaqi
    Tan, Huiwen
    Yu, Yerong
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2022, 11 (08): : 930 - 937
123